Health insurers Cigna and Humana are in talks for a merger, the Wall Street Journal reported on Wednesday, citing people familiar with the matter.

Shares of Cigna fell on Wednesday after a report that the company is in talks with Humana about a merger between the two health care giants.

Managed-care providers Cigna Group CI, -2.76% and Humana Inc. HUM, +0.17% are in talks to combine in a cash-and-stock deal that could be finalized before year-end, the Wall Street Journal reported ...

A cash-and-stock deal between the health-insurance giants could be struck by year-end.

Rising premiums, contract wins, a telehealth services suite and the M&A strategy are expected to drive the performances of the Zacks Medical-HMO industry players. UNH, CI, HUM, CNC and MOH are pois...

Cigna's (CI) sub-unit Express Scripts introduces a pricing option for prescription drugs that may bolster the customer base and fetch higher pharmacy revenues to the health insurer.

Cigna Group is a leading health insurance and pharmacy benefits provider in the US, with a strong customer base and growth potential. The company's repositioning towards high-growth areas allows it...

The SPDR S&P 500 ETF posted its third consecutive losing month in October, the first time this has happened since I started tracking this series in September 2020. The top 15 dividend growth stocks...

Cigna (CI) came out with quarterly earnings of $6.77 per share, beating the Zacks Consensus Estimate of $6.66 per share. This compares to earnings of $6.04 per share a year ago.

Cigna Group Inc. CI, +0.07% topped quarterly revenue expectations Thursday while logging increased counts of pharmacy and medical customers. The company recorded third-quarter net income of $1.4 bi...

Cigna Corp raised its full-year profit forecast on Thursday, banking on strength in its pharmacy benefit unit and lower-than-expected insurance claims.

Blue-chip companies are very well established, have an excellent reputation and boast a history of providing investors with consistent returns. Blue-chip stocks are a must for investors because the...

Evaluate the expected performance of Cigna (CI) for the quarter ended September 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics...

Cigna's (CI) third-quarter results are likely to reflect growth in medical customers and pharmacy revenues.

Value stocks are important in a high interest rate environment and tend to perform well compared to growth companies. Cigna Group is a cheap stock with strong historical financial performance and s...